Lakefront Biotherapeutics NV Stock
Stocks
LKFT
BE0003818359
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.34 EUR | +3.84% |
|
+5.00% | -13.07% |
| Market Cap | 1.6B 1.85B 1.5B 1.37B 2.58B 177B 2.62B 17.61B 6.9B 88.36B 6.95B 6.8B 295B | P/E 2026 * |
-11.4x | P/E 2027 * | -8.62x |
|---|---|---|---|---|---|
| Enterprise Value | -453M -523M -424M -387M -728M -49.86B -740M -4.97B -1.95B -24.95B -1.96B -1.92B -83.25B | EV / Sales 2026 * |
-17x | EV / Sales 2027 * | -8.34x |
| Free-Float |
74.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lakefront Biotherapeutics NV
| 08-10 | Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update | GL |
| 08-04 | Acquisition of Own Shares | GL |
| 07-28 | Acquisition of Own Shares | GL |
| 07-21 | Acquisition of Own Shares | GL |
| 07-14 | Acquisition of Own Shares | GL |
| 1 day | +3.84% | ||
| 1 week | +5.00% | ||
| Current month | +2.01% | ||
| 1 month | -7.52% | ||
| 3 months | +4.02% | ||
| 6 months | -14.30% | ||
| Current year | -13.07% |
| 1 week | 22.32 |  | 24.58 |
| 1 month | 22.32 | | 26.56 |
| Current year | 22.32 | | 30.72 |
| 1 year | 22.32 | | 32.74 |
| 3 years | 20 | | 39 |
| 5 years | 20 | | 66.28 |
| 10 years | 20 | | 252.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Gosebruch
CEO | Chief Executive Officer | 53 | 2025-05-11 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 2025-07-06 |
| Chief Operating Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Linda Higgins
BRD | Director/Board Member | 63 | 2019-10-21 |
Oleg Nodelman
BRD | Director/Board Member | 49 | 2024-10-06 |
Henry Gosebruch
BRD | Director/Board Member | 53 | 2025-05-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/28/26 | Buy | Director | 137 | 0.0002% | ||
| 1/28/26 | Buy | Director | 375 | 0.0006% | ||
| 1/28/26 | Free | General Counsel | 235,000 | 0.3566% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.84% | +5.00% | -10.97% | -32.20% | 1.85B | |
| -0.72% | +3.41% | +6.32% | +16.27% | 49.54B | |
| -0.69% | +6.25% | +492.36% | +585.40% | 44.06B | |
| +0.08% | +11.23% | +23.99% | +81.74% | 40.85B | |
| +0.76% | +6.85% | +35.40% | +10.92% | 40.14B | |
| +4.73% | +13.29% | +27.76% | +54.22% | 34.17B | |
| -0.41% | +4.08% | - | - | 16.78B | |
| +0.51% | +5.29% | +34.62% | +126.87% | 16.9B | |
| -0.20% | +1.57% | +5.49% | +21.35% | 14B | |
| +1.81% | +20.45% | +89.35% | +31.49% | 13.46B | |
| Average | +0.97% | +257.05% | +78.26% | +99.56% | 27.18B | |
| Weighted average by Cap. | +0.59% | +293.85% | +106.68% | +137.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.71M 30.82M 25.01M 22.82M 42.94M 2.94B 43.66M 293M 115M 1.47B 116M 113M 4.91B | 53.46M 61.69M 50.05M 45.67M 85.94M 5.88B 87.38M 587M 230M 2.95B 232M 227M 9.83B |
| Net income | 44.95M 51.87M 42.08M 38.4M 72.25M 4.95B 73.47M 493M 193M 2.48B 195M 191M 8.26B | -113M -130M -105M -96.19M -181M -12.39B -184M -1.24B -484M -6.2B -488M -477M -20.7B |
| Net Debt | -2.06B -2.37B -1.93B -1.76B -3.31B -226B -3.36B -22.58B -8.85B -113B -8.91B -8.72B -378B | -2.05B -2.37B -1.92B -1.75B -3.3B -226B -3.35B -22.5B -8.82B -113B -8.88B -8.69B -377B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | €24.34 | +3.84% | 222,871 |
| 26-08-10 | €23.44 | +0.43% | 100,415 |
| 26-08-07 | €23.34 | +3.83% | 98,146 |
| 26-08-06 | €22.48 | -1.75% | 114,958 |
| 26-08-05 | €22.88 | -1.29% | 89,429 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LKFT Stock
Select your edition
All financial news and data tailored to specific country editions
